TARS logo

TARS
Tarsus Pharmaceuticals Inc

932
Mkt Cap
$2.71B
Volume
576,736.00
52W High
$85.25
52W Low
$38.51
PE Ratio
-39.52
TARS Fundamentals
Price
$63.62
Prev Close
$63.61
Open
$62.79
50D MA
$68.93
Beta
0.74
Avg. Volume
506,327.63
EPS (Annual)
-$1.59
P/B
7.88
Rev/Employee
$1.22M
$3,086.48
Loading...
Loading...
News
all
press releases
D.A. Davidson & CO. Takes $1.49 Million Position in Tarsus Pharmaceuticals, Inc. $TARS
D.A. Davidson & CO. purchased a new stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·5h ago
News Placeholder
More News
News Placeholder
Amgen (AMGN) Q1 Earnings and Revenues Beat Estimates
Amgen (AMGN) delivered earnings and revenue surprises of +8.87% and +1.71%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Jennison Associates LLC Sells 374,511 Shares of Tarsus Pharmaceuticals, Inc. $TARS
Jennison Associates LLC cut its stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 14.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·3d ago
News Placeholder
Tarsus Pharmaceuticals is Now Oversold (TARS)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·6d ago
News Placeholder
Universal Beteiligungs und Servicegesellschaft mbH Increases Holdings in Tarsus Pharmaceuticals, Inc. $TARS
Universal Beteiligungs und Servicegesellschaft mbH grew its position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 19.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 109,857 shares of the...
MarketBeat·6d ago
News Placeholder
Calamos Advisors LLC Makes New $2.82 Million Investment in Tarsus Pharmaceuticals, Inc. $TARS
Calamos Advisors LLC purchased a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) during the fourth quarter, according to its most recent 13F filing with the...
MarketBeat·6d ago
News Placeholder
Tarsus Pharmaceuticals (NASDAQ:TARS) Now Covered by Analysts at Oppenheimer
Oppenheimer began coverage on Tarsus Pharmaceuticals in a report on Friday. They set an "outperform" rating and a $98.00 price target for the company...
MarketBeat·9d ago
News Placeholder
Tarsus Pharmaceuticals, Inc. $TARS Position Increased by M&T Bank Corp
M&T Bank Corp increased its stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 11,730.0% during the 4th quarter, according to the company in its most recent 13F filing with the...
MarketBeat·10d ago
News Placeholder
Tarsus Pharmaceuticals (NASDAQ:TARS) Downgraded to "Hold" Rating by Wall Street Zen
Wall Street Zen cut shares of Tarsus Pharmaceuticals from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·15d ago
News Placeholder
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Down 5.9% - Here's What Happened
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Down 5.9% - What's Next...
MarketBeat·17d ago
<
1
2
...
>

Latest TARS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.